135 related articles for article (PubMed ID: 22333575)
1. Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
Ballana E; Ruiz-de Andres A; Mothe B; Ramirez de Arellano E; Aguilar F; Badia R; Grau E; Clotet B; del Val M; Brander C; Esté JA
Immunobiology; 2012 Sep; 217(9):889-94. PubMed ID: 22333575
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
3. Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades.
Dos Santos JS; de Almeida SM; Ferreira GS; Bordignon J; Maia Teixeira SL; Martins Lima AC; Raboni SM
Curr HIV Res; 2017; 15(6):440-447. PubMed ID: 29210660
[TBL] [Abstract][Full Text] [Related]
4. Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.
Nissen SK; Christiansen M; Helleberg M; Kjær K; Jørgensen SE; Gerstoft J; Katzenstein TL; Benfield T; Kronborg G; Larsen CS; Laursen A; Pedersen G; Jakobsen MR; Tolstrup M; Mogensen TH
Sci Rep; 2018 Oct; 8(1):15253. PubMed ID: 30323326
[TBL] [Abstract][Full Text] [Related]
5. Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients.
Ramírez de Arellano E; Díez-Fuertes F; Aguilar F; de la Torre Tarazona HE; Sánchez-Lara S; Lao Y; Vicario JL; García F; González-Garcia J; Pulido F; Gutierrez-Rodero F; Moreno S; Iribarren JA; Viciana P; Vilches C; Ramos M; Capa L; Alcamí J; Del Val M
PLoS One; 2019; 14(8):e0220459. PubMed ID: 31393887
[TBL] [Abstract][Full Text] [Related]
6. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.
Casado C; Colombo S; Rauch A; Martínez R; Günthard HF; Garcia S; Rodríguez C; Del Romero J; Telenti A; López-Galíndez C
PLoS One; 2010 Jun; 5(6):e11079. PubMed ID: 20552027
[TBL] [Abstract][Full Text] [Related]
7. HIV-specific T-cell Responses and Generalized Activation in HIV-1 Infected Long-term Non-progressors and Progressors from South India.
Swathirajan CR; Vignesh R; Waldrop G; Shanmugasundaram U; Nandagopal P; Solomon SS; Pradeep A; Saravanan S; Murugavel KG
Curr HIV Res; 2018; 16(4):302-314. PubMed ID: 30543175
[TBL] [Abstract][Full Text] [Related]
8. Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
Veloso S; Olona M; García F; Domingo P; Alonso-Villaverde C; Broch M; Peraire J; Viladés C; Plana M; Pedrol E; López-Dupla M; Aguilar C; Gutiérrez M; Leon A; Tasias M; Gatell JM; Richart C; Vidal F
BMC Med Genet; 2010 Apr; 11():63. PubMed ID: 20420684
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profile in long-term non progressor HIV infected patients: in search of potential resistance factors.
Luque MC; Santos CC; Mairena EC; Wilkinson P; Boucher G; Segurado AC; Fonseca LA; Sabino E; Kalil JE; Cunha-Neto E
Mol Immunol; 2014 Nov; 62(1):63-70. PubMed ID: 24967879
[TBL] [Abstract][Full Text] [Related]
10. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.
Pereyra F; Addo MM; Kaufmann DE; Liu Y; Miura T; Rathod A; Baker B; Trocha A; Rosenberg R; Mackey E; Ueda P; Lu Z; Cohen D; Wrin T; Petropoulos CJ; Rosenberg ES; Walker BD
J Infect Dis; 2008 Feb; 197(4):563-71. PubMed ID: 18275276
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
Catano G; Kulkarni H; He W; Marconi VC; Agan BK; Landrum M; Anderson S; Delmar J; Telles V; Song L; Castiblanco J; Clark RA; Dolan MJ; Ahuja SK
PLoS One; 2008; 3(11):e3636. PubMed ID: 18982067
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
Dominguez-Molina B; Tarancon-Diez L; Hua S; Abad-Molina C; Rodriguez-Gallego E; Machmach K; Vidal F; Tural C; Moreno S; Goñi JM; Ramírez de Arellano E; Del Val M; Gonzalez-Escribano MF; Del Romero J; Rodriguez C; Capa L; Viciana P; Alcamí J; Yu XG; Walker BD; Leal M; Lichterfeld M; Ruiz-Mateos E;
Clin Infect Dis; 2017 Mar; 64(5):621-628. PubMed ID: 27986689
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.
Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
AIDS; 2009 Jun; 23(9):1163-9. PubMed ID: 19444075
[TBL] [Abstract][Full Text] [Related]
14. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H
Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073
[TBL] [Abstract][Full Text] [Related]
15. An additive effect of protective host genetic factors correlates with HIV nonprogression status.
Salgado M; Simón A; Sanz-Minguela B; Rallón NI; López M; Vicario JL; Benito JM; Rodés B
J Acquir Immune Defic Syndr; 2011 Apr; 56(4):300-5. PubMed ID: 21084992
[TBL] [Abstract][Full Text] [Related]
16. HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
Thomas R; Apps R; Qi Y; Gao X; Male V; O'hUigin C; O'Connor G; Ge D; Fellay J; Martin JN; Margolick J; Goedert JJ; Buchbinder S; Kirk GD; Martin MP; Telenti A; Deeks SG; Walker BD; Goldstein D; McVicar DW; Moffett A; Carrington M
Nat Genet; 2009 Dec; 41(12):1290-4. PubMed ID: 19935663
[TBL] [Abstract][Full Text] [Related]
17. Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.
Gaardbo JC; Hartling HJ; Ronit A; Thorsteinsson K; Madsen HO; Springborg K; Gjerdrum LM; Birch C; Laye M; Ullum H; Andersen ÅB; Nielsen SD
PLoS One; 2013; 8(5):e63744. PubMed ID: 23696852
[TBL] [Abstract][Full Text] [Related]
18. Higher SLPI expression, lower immune activation, and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
Taborda NA; Cataño JC; Delgado JC; Rugeles MT; Montoya CJ
J Acquir Immune Defic Syndr; 2012 May; 60(1):12-9. PubMed ID: 22240462
[TBL] [Abstract][Full Text] [Related]
19. RICH2 is implicated in viraemic control of HIV-1 in black South African individuals.
Paximadis M; Ngqobe RN; Chaisson RE; Martinson NA; Tiemessen CT
Infect Genet Evol; 2017 Apr; 49():78-87. PubMed ID: 28069446
[TBL] [Abstract][Full Text] [Related]
20. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
[Next] [New Search]
